Abeona Therapeutics
ABEO
Abeona Therapeutics (ABEO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.35
- EPS estimate
- −$0.23
- EPS surprise
- −51.06%
- Revenue surprise
- −7.01%
- Revenue
- $11.4M
- Revenue estimate
- $12.2M
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$0.23 | −$0.35 | −51.06% | $11.4M | SEC |
| Q1 2026 | May 13, 2026 | −$0.34 | −$0.30 | +10.45% | $8.7M | SEC |
| Q4 2025 | Mar 17, 2026 | −$0.35 | −$0.36 | −2.27% | $5.4M | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.28 | −$0.10 | +64.54% | $0.00 | SEC |
| Q2 2025 | Aug 14, 2025 | −$0.39 | $1.71 | +538.46% | $400,000.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.36 | −$0.24 | +32.96% | $0.00 | SEC |
| Q4 2024 | Mar 20, 2025 | −$0.35 | $0.50 | +243.68% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.40 | −$0.63 | −55.94% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.34 | −$0.26 | +23.98% | $0.00 | SEC |
| Q1 2024 | May 15, 2024 | −$0.51 | −$1.16 | −125.99% | $0.00 | SEC |
| Q4 2023 | Mar 18, 2024 | −$0.47 | −$0.59 | −25.53% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.53 | −$0.48 | +9.99% | $0.00 | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.67 | −$0.92 | −36.64% | $3.5M | SEC |
| Q1 2023 | May 11, 2023 | −$0.61 | −$0.54 | +11.48% | $0.00 | SEC |
| Q4 2022 | Mar 29, 2023 | −$0.75 | −$0.06 | +91.51% | $68,000.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$1.75 | −$1.48 | +15.27% | $0.00 | — |
| Q2 2022 | Aug 11, 2022 | −$1.88 | −$2.08 | −10.93% | $1.0M | — |
| Q1 2022 | May 13, 2022 | −$2.38 | −$3.50 | −47.37% | $346,000.00 | — |
| Q4 2021 | Mar 31, 2022 | −$3.67 | −$11.25 | −206.82% | $3.0M | — |
| Q3 2021 | Nov 15, 2021 | −$4.00 | −$1.75 | +56.25% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Abeona Therapeutics (ABEO) last report earnings?
Abeona Therapeutics last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did ABEO beat earnings estimates?
No. Abeona Therapeutics reported EPS of −$0.35 for Q2 2026 against a −$0.23 estimate — a 51.06% miss.
How much revenue did ABEO report last quarter?
Abeona Therapeutics reported $11.4M in revenue for Q2 2026, against a consensus estimate of $12.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.